Dr. Reddy's Laboratories Ltd Common Stock vs Vicor Corporation Common Stock — how do they compare? Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B), while Vicor Corporation Common Stock trades at $238.97 (market cap $12.30B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock and Vicor Corporation Common Stock are close in size by market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Vicor Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dr. Reddy's Laboratories Ltd Common Stock for 0 Days and Vicor Corporation Common Stock for 0 Days on average.
| RDY | VICR | |
|---|---|---|
Market Cap | $10.78B | $12.30B |
Volume | 2,724,343 | 1,052,269 |
Sector | Health | Technology |
52-Week High | $15.38 | $379.78 |
52-Week Low | $11.38 | $57.31 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.68B | $11.86B |
Dividend Yield | 0.65% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →Vicor Corporation designs, manufactures, and markets modular power components and complete power systems, serving high-performance computing, data center, industrial, automotive, and aerospace and defense markets.
Read more on VICR →